201 related articles for article (PubMed ID: 24167378)
1. Levels of circulating microparticles in lung cancer patients and possible prognostic value.
Tseng CC; Wang CC; Chang HC; Tsai TH; Chang LT; Huang KT; Leu S; Yen CH; Liu SF; Chen CH; Yang CT; Yip HK; Lin MC
Dis Markers; 2013; 35(5):301-10. PubMed ID: 24167378
[TBL] [Abstract][Full Text] [Related]
2. Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancer.
Wang CC; Tseng CC; Hsiao CC; Chang HC; Chang LT; Fang WF; Leu S; Wang YH; Tsai TH; Yang CT; Chen CH; Yip HK; Ho CK; Lin MC
Biomed Res Int; 2014; 2014():173401. PubMed ID: 25061601
[TBL] [Abstract][Full Text] [Related]
3. Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.
Tseng CC; Wang CC; Hsiao CC; Lu HI; Leu S; Chang HC; Huang KT; Fang WF; Chen YM; Liu SF; Yang CT; Lin MC; Yip HK
Tumour Biol; 2016 Sep; 37(9):11873-11882. PubMed ID: 27059732
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial cells and microparticles as diagnostic and prognostic biomarkers in small-cell lung cancer.
Najjar F; Alammar M; Al-Massarani G; Almalla N; Japawe A; Ikhtiar A
Lung Cancer; 2018 Oct; 124():23-30. PubMed ID: 30268466
[TBL] [Abstract][Full Text] [Related]
5. Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles.
Liu T; Wang J; Li T; Cui P; Hou B; Zhuang C; Wei G; Zhang S; Li H; Hu Y
BMC Cancer; 2021 Aug; 21(1):939. PubMed ID: 34416874
[TBL] [Abstract][Full Text] [Related]
6. Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients.
Wang CC; Tseng CC; Chang HC; Huang KT; Fang WF; Chen YM; Yang CT; Hsiao CC; Lin MC; Ho CK; Yip HK
Oncotarget; 2017 Sep; 8(44):75952-75967. PubMed ID: 29100283
[TBL] [Abstract][Full Text] [Related]
7. Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer.
Haghbin M; Hashemi Tayer A; Kamravan M; Sotoodeh Jahromi A
Asian Pac J Cancer Prev; 2021 May; 22(5):1573-1579. PubMed ID: 34048188
[TBL] [Abstract][Full Text] [Related]
8. Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD.
Tőkés-Füzesi M; Ruzsics I; Rideg O; Kustán P; Kovács GL; Molnár T
Int J Chron Obstruct Pulmon Dis; 2018; 13():3749-3757. PubMed ID: 30532530
[TBL] [Abstract][Full Text] [Related]
9. Circulating endothelial cells and microparticles for prediction of tumor progression and outcomes in advanced non-small cell lung cancer.
Najjar F; Alammar M; Al-Massarani G; Almalla N; Aljapawe A; Ikhtiar A
Cancer Biomark; 2017 Sep; 20(3):333-343. PubMed ID: 28800312
[TBL] [Abstract][Full Text] [Related]
10. Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer.
Fleitas T; Martínez-Sales V; Vila V; Reganon E; Mesado D; Martín M; Gómez-Codina J; Montalar J; Reynés G
PLoS One; 2012; 7(10):e47365. PubMed ID: 23077602
[TBL] [Abstract][Full Text] [Related]
11. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
12. HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection.
Abbate V; Marcantoni M; Giuliante F; Vecchio FM; Gatto I; Mele C; Saviano A; Arciuolo D; Gaetani E; Ferrari MC; Giarretta I; Ardito F; Riccardi L; Nicoletti A; Ponziani FR; Gasbarrini A; Pompili M; Pola R
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498353
[TBL] [Abstract][Full Text] [Related]
13. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
14. Level and Value of T Cell-derived Circulating Microparticles in Liver Cirrhosis Patients.
Chen CH; Chang CL; Chen KH; Cheng BC; Chen HH; Chiang JY; Sung PH; Yip HK
In Vivo; 2019; 33(6):2265-2272. PubMed ID: 31662566
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance and Roles in Angiogenesis of Circulating Microparticles in Oral Cancer.
Ren JG; Zhang W; Liu B; Man QW; Xiong XP; Li C; Zhu JY; Wang WM; Jia J; Sun ZJ; Zhang WF; Chen G; Zhao YF
J Dent Res; 2016 Jul; 95(8):860-7. PubMed ID: 27013642
[TBL] [Abstract][Full Text] [Related]
16. Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemia.
Sheu JJ; Lee FY; Wallace CG; Tsai TH; Leu S; Chen YL; Chai HT; Lu HI; Sun CK; Yip HK
J Transl Med; 2015 Feb; 13():59. PubMed ID: 25889721
[TBL] [Abstract][Full Text] [Related]
17. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis.
Berezin AE; Kremzer AA; Berezina TA; Martovitskaya YV
Acta Clin Belg; 2016 Feb; 71(1):38-45. PubMed ID: 27075791
[TBL] [Abstract][Full Text] [Related]
18. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay.
Ayers L; Kohler M; Harrison P; Sargent I; Dragovic R; Schaap M; Nieuwland R; Brooks SA; Ferry B
Thromb Res; 2011 Apr; 127(4):370-7. PubMed ID: 21257195
[TBL] [Abstract][Full Text] [Related]
19. Elevated Level of Circulating Platelet-derived Microparticles in Oral Cancer.
Ren JG; Man QW; Zhang W; Li C; Xiong XP; Zhu JY; Wang WM; Sun ZJ; Jia J; Zhang WF; Zhao YF; Chen G; Liu B
J Dent Res; 2016 Jan; 95(1):87-93. PubMed ID: 26124218
[TBL] [Abstract][Full Text] [Related]
20. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
Front Immunol; 2018; 9():322. PubMed ID: 29545790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
